An experimental study of enhanced anticancer effect of intraperitoneal chemotherapy with high energy shock waves
An experimental study of enhanced anticancer effect of intraperitoneal chemotherapy with high energy shock waves
批准号:
06671277
负责人:
TSUJITANI Shunichi
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
体外观察顺铂腹腔注射抗肿瘤活性。将Erhlich腹水癌细胞悬浮于含5-50杯/ml顺铂的生理盐水中30分钟,测定细胞内对顺铂的摄取。依氏细胞吸收的顺铂积累量与顺铂浓度成比例增加。10杯/毫升顺铂溶液中顺铂的细胞摄取按时间顺序增加。然后研究腹腔注射顺铂和体外低水平超声对小鼠体内的影响。通过腹腔注射Erhlich细胞诱导小鼠腹膜癌变。在细胞注射后24和94小时,以5 mg/kg的剂量给予顺铂溶液50 mg/ ml。超声波(28khz)照射小鼠3分钟、5分钟或10分钟。在细胞注射后24小时处理小鼠时,未处理组的中位生存天数分别为11.5、14.5、14.0、21.5和23天,分别为单药组、3分钟超声波组、5分钟超声波组和10分钟超声波组。腹腔注射顺铂和5、10分钟超声治疗组荷瘤小鼠的生存期明显延长(P<0.01, Cox-Mantel检验)。注射细胞后96 h,小鼠的中位生存天数分别为:不治疗组、单用顺铂组、超声波3分钟组、超声波5分钟组和超声波10分钟组的中位生存天数分别为12.0、16.0、15.5、22.0和24.5天。腹腔注射顺铂和5、10分钟超声治疗比不治疗和单独使用顺铂组的小鼠生存期明显延长(P<0.01, Cox-Mantel检验)。提示腹腔顺铂联合体外低水平超声治疗腹膜播散比单用顺铂治疗更有效。少
英文摘要
Antitumor activity of intraperitoneal cisplatin was examined in vitro. Erhlich ascites carcinoma cells were suspended in phyisiolosic saline which contained 5-50 mug/ml of cisplatin for 30 minutes, and intracellular uptake of cisplatin was measured. The accumulation of cisplatin taken up by Erhlich cells increased in proportion to the concentration of cisplatin. The cellular uptake of cisplatin in 10 mug/ml cisplatin solution increased chronologically. Then in vivo effects of intraperitoneal cisplatin and extracorporeal low-level ultrasonic waves were studied. A peritoneal carcinomatosis was induced in ddy mice by intraperitoneal injection of Erhlich cells. At 24 and 94 hours after cell injection, cisplatin solution (50 mug/ml) was administered at a dose of 5 mg/kg to ddy mice. Ultrasonic waves (28 kHz) were irradiated to mice for 3,5, or 10 minutes. When mices were treated at 24 hours after cell injection, the median survival days were 11.5,14.5,14.0,21.5 and 23 in the no-treatment, c … More isplatin alone, 3-minute ultrasonic waves, 5-minute ultrasonic waves and 10-minutes ultrasonic waves, respectively. The survival of intraperitoneal tumor-bearing ddy mice was greatly prolonged by intraperitoneal cisplatin and 5- or 10-minute ultrasonic waves as compared with those of the no-treatment or cisplatin aalone (P<0.01, Cox-Mantel test). When mices were treated at 96 hours after cell injection, the median survival days were 12.0 16.0,15.5,22.0 and 24.5 in the no-treatment, cisplatin alone, 3-minute ultrasonic waves, 5-minute ultrasonic waves and 10-minutes ultrasonic waves, respectively. The survival of intraperitoneal tumor-bearing ddy mice was greatly prologned by intraperitoneal cisplatin and 5- or 10-minute ultorasonic waves as compared with those of the no-treatment or cisplatin alone (P<0.01, Cox-Mantel test). These results indicate that the combination of intraperitoneal cisplatin and extracorporeal low-level ultrasonic waves may prevent and treat the peritoneal dissemination more effectively than the treatment of intraperitoneal cisplatin alone. Less
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
岡 淳夫: "低浸透圧シスプラチン腹腔内化学療法の制癌効果増強に関する実験的検討" 米子医学雑誌. 47. 81-93 (1996)
Atsuo Oka:“增强低渗透顺铂腹腔化疗抗癌效果的实验研究”米子医学杂志47. 81-93(1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
近藤 亮: "シスプラチン腹腔内化学療法の抗腫瘍性に及ぼす溶液浸透圧の影響" 米子医学雑誌. 45. 54-69 (1994)
Ryo Kondo:“溶液渗透压对腹腔内顺铂化疗抗肿瘤特性的影响”米子医学杂志 45. 54-69 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oka, Atsuo: "An experimental study on enhanced anticancer effect of intraperitoneal hypotonic cisplatin chemotherapy" J Yonago Med Ass. 47. 81-93 (1996)
Oka, Atsuo:“腹腔内低渗顺铂化疗增强抗癌作用的实验研究”J Yonago Med Ass。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kondo, Akira: "Effect of fulid osmolarity on antitumor activity of intraperitoneal cisplatin chemotherapy" J Yonago Med Ass. 45. 54-69 (1994)
Kondo,Akira:“液体渗透压对腹腔内顺铂化疗抗肿瘤活性的影响”J Yonago Med Ass。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Peritoneal dissemination of gastric cancer stem cells and immunotherapy overcoming immune escape
-
批准号:23591939
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2011
-
负责人:TSUJITANI Shunichi
-
依托单位:
Establishment of dendritic cell immunotherapy based on the chemokine expression profile of cancer cells
-
批准号:14370357
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.87万
-
财政年份:2002
-
负责人:TSUJITANI Shunichi
-
依托单位:
Establishment of tumor-specific dendritic cell vaccine pulsed by tumor-derived heat shock protein or cell fusion with tumor cells
-
批准号:11470247
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.04万
-
财政年份:1999
-
负责人:TSUJITANI Shunichi
-
依托单位:
Effects of telomerase and intracellular signal transduction pathways on carcinogenesis and development of colorectal carcinoma
-
批准号:08671442
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1996
-
负责人:TSUJITANI Shunichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Entpd5在上皮性卵巢癌对Cisplatin继发耐药中的分子作用机制研究
-
批准号:81703078
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:黄莉萍
-
依托单位:
构建基于TRAIL-exosome的siRNA和Cisplatin共载纳米系统及治疗耐药宫颈癌的研究
-
批准号:81671809
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:朱雪琼
-
依托单位:
CUDC-101联合cisplatin对卵巢癌腹水细胞spheroid形成及转移机制的相关研究
-
批准号:81402127
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2014
-
负责人:孟凡良
-
依托单位:
XPC表达变异改变膀胱尿路上皮癌对Cisplatin敏感性的实验研究
-
批准号:30340057
-
项目类别:专项基金项目
-
资助金额:9.0万元
-
批准年份:2003
-
负责人:陈志文
-
依托单位: